Hit enter to search or ESC to close
ERA4TBERA4TBERA4TB
  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
Category

Event

Event

Europa Press Digital Meetings: AIDS, tuberculosis and malaria in times of COVID-19

As part of their online initiative to allow experts to discuss a variety of topics,…
IT Synapse
IT SynapseNovember 30, 2020
Event

ERA4TB Kick off Meeting

The European Regimen Accelerator For Tuberculosis (ERA4TB) Consortium meet in Madrid during two full days…
admin
adminJanuary 28, 2020
Previous 1 2

Recent Posts

  • ERA4TB members attend key meetings on Antimicrobial Resistance in Basel
  • ERA4TB to partner with UNITE4TB for webinar focusing on community engagement in TB research
  • 6th Consortium Meeting, 25-26th January 2023 – ERA4TB partners gather for a face-to-face event in Paris
  • ERA4TB marks its halfway point with 6th Consortium meeting in Paris
  • SAVE THE DATE: ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives

Categories

  • Event
  • News
  • Press

TWITTER

ERA4TB ProjectFollow

Research consortium developing new treatments for TB European Regimen Accelerator for Tuberculosis Grant Agreement no. 853989 — ERA4TB https://t.co/BXboc1TV3r

ERA4TB Project
5h

📢📢 TOMORROW 4-5pm CET📢📢

Don't miss our webinar with @UNITE4TB happening tomorrow to mark #WorldTBDay2023 on why and how to involve people affected by #tuberculosis in early-stage/pre-clinical research

👉Sign-up to attend: https://bit.ly/3yXGhIf

Reply on Twitter 1638494828844515328Retweet on Twitter 16384948288445153281Like on Twitter 16384948288445153281Twitter 1638494828844515328
21 Mar

Only two days to go until our webinar with @UNITE4TB to mark #WorldTBday2023

We will be hearing the lived experience of a TB survivor and activist and will be exploring the benefits and challenges to community involvement in pre-clinical research
Sign-up: https://bit.ly/3Jx1IF0

Reply on Twitter 1638098518714855426Retweet on Twitter 16380985187148554269Like on Twitter 163809851871485542613Twitter 1638098518714855426
Retweet on TwitterERA4TB Project Retweeted
17 Mar

We created a first-of-its-kind payment model for 2 new antimicrobials with @NHSEngland & @DHSCgovuk.

The model incentivises the development of new products while upholding antimicrobial stewardship, with payments based on value to the NHS, not volume sold https://www.nice.org.uk/news/blog/nice-leads-the-way-to-develop-a-new-approach-to-routinely-value-and-pay-for-crucial-antimicrobials

Reply on Twitter 1636771660987613204Retweet on Twitter 16367716609876132042Like on Twitter 16367716609876132042Twitter 1636771660987613204
Retweet on TwitterERA4TB Project Retweeted
17 Mar

#HappeningSoon
For 4 days, the ancient city of Varanasi, India becomes the brain and heart of the global TB response.
📌Read https://mailchi.mp/stoptb.org/stop-tb-partnership-end-of-year-message-831509?e=5d5565b21a #YesWeCanEndTB #EndTB

Reply on Twitter 1636836191839432706Retweet on Twitter 163683619183943270613Like on Twitter 163683619183943270616Twitter 1636836191839432706
Retweet on TwitterERA4TB Project Retweeted
17 Mar

Excellent presentations from Dr. Ferrer and Dr. Lucía @IMI_ERA4TB
Great panel discussion on TB regimen development linking pre-clinical to clinical development.
With Martin Boeree and Norbert Heinrich @UNITE4TB https://twitter.com/IMI_ERA4TB/status/1636658245677772801

ERA4TB Project@IMI_ERA4TB

Make sure you catch ERA4TB’s Ainhoa Lucía @Ainhoa_LQ , from @unizar and Santiago Ferrer Bazaga, from @ServInvestUC3M speaking in the ‘Towards better treatment combination against tuberculosis’ session at the 7th AMR Conference today in Basel!

The session is on at 13.30-14.30 CET

Reply on Twitter 1636761213953773573Retweet on Twitter 16367612139537735734Like on Twitter 163676121395377357313Twitter 1636761213953773573
Load More...
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2023 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.